Why This Is a Huge Win Against Prostate Cancer
Myovant Sciences shares more than doubled on Tuesday after the firm announced results from its Phase 3 Hero study of relugolix for prostate cancer.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 80
Will Medicines Co Be the Next Target of Novartis?
Medicines shares shot up on Tuesday after it was reported that Novartis might be eyeing this company as its newest acquisition.
This Is the Unhealthiest State in America
The unhealthiest state in the union, according to statistics compiled by LetsGetChecked, a home health and wellness testing site, is West Virginia. The healthiest state by the same metrics is Utah. Using data from…
New Schizophrenia Study May Usher in Game-Changing Standard of Care
On top of the potential game-changer for schizophrenia patients, some Karuna Therapeutics investors just experienced the same euphoria as holding a winning lottery ticket.
AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses
Here are five health-care-related stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross.
Health Care Data Breaches May Cost More Than Money
Cybercrime against health care organizations is rising and it is not only costing the victims money, it lowers their quality of care for years after.
resTORbio Becomes Next Biotech Implosion, and Other Indications May Not Matter
There is a huge risk-reward factor in emerging pharmaceutical and biotech companies that happen to have all their eggs in just one basket. That's the case of resTORbio.
The Threat From Antibiotic-Resistant Germs Gets Scarier
In a new report on antibiotic-resistant germs, the CDC highlights the rising levels of risk and what we must do to control the risk of spreading these germs.
Is Tilray’s Growth Enough for Investors?
Tilray released its third quarter financial results after the closing bell on Tuesday. The company said that it had a net loss of $0.50 per share and $51.1 million in revenue, compared with consensus…
Is This DMD Study Sunk After FDA Update?
Solid Bio shares were absolutely crushed on Tuesday after the firm announced that the FDA has placed its Ignite DMD Phase 1/2 study of SGT-001 on hold.
Major Biotechs See Rising Tide in Short Interest
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in most of these…
Big Pharma Scares Off Short Sellers
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Is Vaping Really Worse Than Smoking?
Two new studies that will be reported later this week suggest a link between using e-cigarettes and reduced heart health.
Why Investors Are Pumping the Brakes on NextCure’s Cancer Treatment
NextCure updated clinical results from its early stage cancer study at the Society for Immunotherapy of Cancer annual meeting. As a result, NextCure shares were crushed on Monday.
Is This FDA Update the Death of Lipocine?
Lipocine shares absolutely plummeted on Monday after the firm announced that it received a Complete Response Letter from the FDA regarding its New Drug Application for Tlando.